Company performance
Add to research
Current Price
as of Mar 20, 2025$4.27
P/E Ratio
N/A
Market Cap
$35.55M
Description
Add to research
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Metrics
Add to research
Overview
- HQSalt Lake City, UT
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCLNN
- Price$4.27-0.93%
Trading Information
- Market cap$35.55M
- Float64.63%
- Average Daily Volume (1m)36,976
- Average Daily Volume (3m)52,973
- EPS-$0.28
Company
- Revenue$0.42M
- Rev growth (1yr)-19.44%
- Net income-$7.99M
- Gross margin-387.36%
- EBITDA margin-8,516.09%
- EBITDA-$7.41M
- EV$610.25M
- EV/Revenue1,449.51
- P/EN/A
- P/S1,330.26
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Factset